TMC and Denmark have formed a BioBridge agreement that will address advancements in the following areas to improve patient health and care experiences:
· Digital health/telehealth.
· Medical device innovation.
· Hospital service and operations models.
The BioBridge partnership also supports clinical research and education, including the identification of current and potential trial activity for collaboration as well as building on opportunities for precision and personalized medicine.
More articles on innovation:
The strategy behind building a top innovation team at 7 health systems
Northeastern University establishes $50M AI institute to address challenges in healthcare
Johnson & Johnson launches innovation challenge
